News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

JOSE MAURO PERALTA, MD, PHD

Advertisement

Articles by JOSE MAURO PERALTA, MD, PHD

Is Investment in New Technologies for Diagnosing Schistosomiasis Justified in an Era of Schistosoma Elimination?

ByMarta G. Cavalcanti, MD, PhD,JOSE MAURO PERALTA, MD, PHD
June 25th 2018

The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.

Advertisement

Latest Updated Articles

  • Is Investment in New Technologies for Diagnosing Schistosomiasis Justified in an Era of Schistosoma Elimination?
    Is Investment in New Technologies for Diagnosing Schistosomiasis Justified in an Era of Schistosoma Elimination?

    Published: June 25th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Maternal and Infant RSV Immunization Safe, Boosts Antibody Levels Regardless of Sequence

2

ViiV Healthcare Announces 96-Week PASO DOBLE Results Showing Dovato as Effective as Biktarvy in Maintaining Viral Suppression

3

HIV Providers: Shortages and Uneven Distribution Across the US

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us